Yoo Jin-Hong
Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
J Korean Med Sci. 2025 Jun 16;40(23):e187. doi: 10.3346/jkms.2025.40.e187.
The rapid rise of generative artificial intelligence (AI) is fundamentally transforming the landscape of medical writing and publishing. In response, major academic organizations and high-impact journals have released guidelines addressing core ethical concerns, including authorship qualification, disclosure of AI use, and the attribution of accountability. This review analyzes and compares key statements from several international medical or scientific editors' organizations along with submission policies of major leading journals. It also evaluates the AI usage policy of the (), which presents one of the most specific frameworks among Korean journals, and offers suggestions for refinement. While most journals prohibit listing AI tools as authors, their stance on AI-assisted writing varies. aligns with international norms by prohibiting AI authorship and recommending that authors explicitly report the tool name, prompt, purpose, and scope of AI use. This policy demonstrates a flexible but principled approach to AI integration. The limitations of AI detection tools are also discussed. These tools often struggle with accuracy and bias, with known tendencies to misclassify human-written content as AI-generated. As such, sole reliance on detection tools is insufficient for editorial decisions. Instead, fostering a culture of ethical authorship and responsible disclosure remains essential. This review highlights the need for balanced policies that promote transparency without impeding innovation. By clarifying disclosure expectations and reinforcing human accountability, journals can guide the ethical use of AI in scientific writing and maintain the integrity of scholarly communication.
生成式人工智能（AI）的迅速崛起正在从根本上改变医学写作和出版的格局。对此，主要学术组织和高影响力期刊发布了相关指南，以解决核心伦理问题，包括作者资格、AI 使用的披露以及责任归属。本综述分析并比较了几个国际医学或科学编辑组织的关键声明以及主要领先期刊的投稿政策。它还评估了（）的 AI 使用政策，该政策在韩国期刊中呈现出最具体的框架之一，并提出了完善建议。虽然大多数期刊禁止将 AI 工具列为作者，但它们对 AI 辅助写作的立场各不相同。（某期刊）通过禁止 AI 署名并建议作者明确报告工具名称、提示词、目的和 AI 使用范围，与国际规范保持一致。该政策展示了一种对 AI 整合灵活但有原则的方法。还讨论了 AI 检测工具的局限性。这些工具在准确性和偏差方面常常存在问题，存在将人工撰写的内容误分类为 AI 生成内容的已知倾向。因此，仅依靠检测工具不足以做出编辑决策。相反，培育道德作者文化和负责任的披露仍然至关重要。本综述强调需要制定平衡的政策，在促进透明度的同时不妨碍创新。通过明确披露期望并加强人类责任，期刊可以引导在科学写作中道德使用 AI，并维护学术交流的完整性。
